Inventor · disambiguated record
Prasada Rao Jalagam
Also filed as: JALAGAM PRASADA RAO
13 granted patents·6 pending applications·14 citations·filing 2016–2024
85Inventor score
Top patents by PatentIndex Score
19 records- 0188US10669272B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 2, 2020·4 cites·13 claims
- 0287US11267811B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 8, 2022·4 cites·20 claims
- 0380US11072626B2Small molecule inhibitors of Galectin-3BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 27, 2021·3 cites·20 claims
- 0480US2024400563A1Substituted pyridopyrimidinonyl compounds useful as t cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0579US10544120B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·2 cites·3 claims
- 0674US2023151007A1Substituted pyridopyrimidinonyl compounds useful as t cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0771US10246469B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·8 claims
- 0867US11713316B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 1, 2023·0 cites·11 claims
- 0966US11584747B2Substituted pyridopyrimidinonyl compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 21, 2023·0 cites·33 claims
- 1064US2024199584A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1161US10954238B1Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 23, 2021·0 cites·11 claims
- 1256US12275720B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB·Filed 2021·Granted Apr 15, 2025·0 cites·13 claims
- 1355US2024108654A1Combination of a t cell therapy and a dgk inhibitorJUNO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1454US11964973B2Substituted bicyclic compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 23, 2024·0 cites·11 claims
- 1553US12286424B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Apr 29, 2025·0 cites·19 claims
- 1653US12269819B2Small molecule inhibitors of Galectin-3BRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 8, 2025·0 cites·13 claims
- 1752US2023086933A1Substituted heteroaryl compounds useful as t cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1851US2023089255A1Combinations of dgk inhibitors and checkpoint antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1948US11970511B2Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 30, 2024·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Prasada Rao Jalagam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →